Botanical species · safety record

Chenopodium quinoa

The EFSA Compendium of Botanicals holds 5 constituent measurements and 1 adverse-effect record for Chenopodium quinoa. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Chenopodium quinoa Wiild.

5Constituent measurements

1Safety records

4Cited sources

209Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 209 licensed products naming Chenopodium quinoa as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Source material stated

Chenopodium quinoa - seed
New material
Seed
Seed(s)
Sprout(s)
Sprouted seed

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Phytic acid	Seed	Solvent extraction	10 Gram/kilogram	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
Saponins	Seed	Solvent extraction	≥ 5.6 Percent	HPLC-DAD	Resolve DOI
Saponins	Seed	Solvent extraction	≤ 7.5 Percent	HPLC-DAD	Resolve DOI
Steroidal saponins	Seed	—	≥ 0.06 Percent	Unspecified	Resolve DOI
Steroidal saponins	Seed	—	≤ 5.1 Percent	Unspecified	Resolve DOI

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
None	—	Husk	Solvent extraction	House mouse (as animal)	Short-term toxicity	Resolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Estrada, A., Li, B., Laarveld, B. Adjuvant action of Chenopodium guinea saponins on the induction of antibody responses to intragastric and intranasal administered antigens in mice. COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES, 1998, vol. 21, no. 3, p. 225-236. DOI
RUALES, J., NAIR, BM. SAPONINS, PHYTIC ACID, TANNINS AND PROTEASE INHIBITORS IN QUINOA (CHENOPODIUM-QUINOA, WILLD) SEEDS. FOOD CHEMISTRY, 1993, vol. 48, no. 2, p. 137-143. DOI
Maria Gomez-Caravaca, Ana., Segura-Carretero, Antonio., Fernandez-Gutierrez, Alberto., Caboni, Maria Fiorenza. Simultaneous Determination of Phenolic Compounds and Saponins in Quinoa (Chenopodium quinoa Willd) by a Liquid Chromatography-Diode Array Detection-Electrospray Ionization-Time-of-Flight Mass Spectrometry Methodology . Journal of agricultural and food chemistry, 2011, vol. 59, no. 20, p. 10815-10825. DOI
Lopez, Laura M., Capparelli, Aylen., Nielsen, Axel Emil. Traditional post-harvest processing to make quinoa grains (Chenopodium quinoa var. quinoa) apt for consumption in Northern Lipez (Potosi, Bolivia): ethnoarchaeological and archaeobotanical analyses . Archaeological and anthropological sciences, 2011, vol. 3, no. 1, p. 49-70. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature